MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ijpharm.2024.124118

Медицинская библиотека · International journal of pharmaceutics · 2024

Nanomicelles empower natamycin in treating fungal keratitis: An in vitro, ex vivo and in vivo study.

Sathe Priyadarshini, Kailasam Velmurugan, Nagarjuna Vasagiri, Sharma Hanuman, Velpandian Thirumurthy, Garg Prashant, Nirmal Jayabalan

СтатьяПеревод пока не подготовлен

Аннотация

Fungal infections of cornea are important causes of blindness especially in developing nations with tropical climate. However, the challenges associated with current treatments are responsible for poor outcome. Natamycin is the only FDA-approved antifungal drug to treat fungal keratitis, but unfortunately due to its poor water solubility, it is available as suspension. The marketed suspension (5% Natamycin) has rapid precorneal clearance, poor corneal permeability, a higher frequency of administration, and corneal irritation due to undissolved suspended drug particles. In our study, we developed clear and stable natamycin-loaded nanomicelles (1% Natcel) to overcome the above challenges. We demonstrated that 1% Natcel could permeate the cornea better than 5% suspension. The developed 1% Natcel was able to provide sustained release for up to 24 h. Further, it was found to be biocompatible and also improved the mean residence time (MRT) than 5% suspension in tears. Therefore, the developed 1% Natcel could be a potential alternative treatment for fungal keratitis.

Для цитирования: Sathe Priyadarshini, Kailasam Velmurugan, Nagarjuna Vasagiri, Sharma Hanuman, Velpandian Thirumurthy, Garg Prashant, Nirmal Jayabalan. Nanomicelles empower natamycin in treating fungal keratitis: An in vitro, ex vivo and in vivo study.. International journal of pharmaceutics. 2024. DOI: 10.1016/j.ijpharm.2024.124118.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.